Repurposing Anti-inflammatory Agents for Mood Disorders: an Updated Review of Current Evidence-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing Anti-inflammatory Agents for Mood Disorders: an Updated Review of Current Evidence

Published:2022-07-08 Issue:4 Volume:9 Page:346-362
ISSN:2196-3061
Container-title:Current Treatment Options in Psychiatry
language:en
Short-container-title:Curr Treat Options Psych

Author:

Kittur Mary E.,Jones Brett D. M.,Dai Nasia,Mahboob Mariam,Husain Muhammad I.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health,Clinical Psychology

Link

https://link.springer.com/content/pdf/10.1007/s40501-022-00267-1.pdf

Reference87 articles.

1. World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. World Health Organization, 2017.

2. Liu Q, He H, Yang J, Feng X, Zhao F, Lyu J. Changes in the global burden of depression from 1990 to 2017: Findings from the Global Burden of Disease study. J Psychiatr Res. 2020;126:134–40.

3. Greenberg PE, Fournier AA, Sisitsky T, Simes M, Berman R, Koenigsberg SH, et al. The economic burden of adults with major depressive disorder in the United States (2010 and 2018). Pharmacoeconomics. 2021;39(6):653–65.

4. Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive meta-analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171(4):453–62.

5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). American Psychiatric Association, 2013.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Inflamed” depression: A review of the interactions between depression and inflammation and current anti-inflammatory strategies for depression;Pharmacological Research;2024-09

2. Molecular hydrogen supplementation in mice ameliorates lipopolysaccharide‐induced loss of interest;Psychiatry and Clinical Neurosciences Reports;2024-08-21

3. Lower levels of TRAF1 in Brodmann's area 24, but not 46, in bipolar disorders are not detectable in major depressive disorders;Journal of Affective Disorders;2024-07

4. Celecoxib for Mood Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Journal of Clinical Medicine;2023-05-16

5. Dramatic elevation of inflammatory cytokines in a patient with periodic depressive episode who responded to anti-inflammatory treatment;Psychiatry Research Case Reports;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3